T Cell Nouveau Inc.
PrivateCompany Overview
T Cell Nouveau Inc. is a clinical-stage biopharmaceutical company that develops Hybrid CAR-T cell therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
CAR-T cell therapysolid tumor treatmentimmunotherapycell manufacturingTCR-T cell therapybiotechgene editingcell processing unitCDMOprecision medicinecell therapy manufacturingnext-gen immunotherapyoncology biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
T Cell Nouveau Inc. Comparables
Compare T Cell Nouveau Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| T-knife Therapeutics | 78% | |
| Shinobi Therapeutics, Inc. | 78% | |
| Immatics N.V. | 70% | |
T Cell Nouveau Inc. Funding Rounds
Historical fundraising activity
T Cell Nouveau Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about T Cell Nouveau Inc.'s valuation, stock price, and market status.
See something wrong or outdated?